Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Diabetes
Interventions
DRUG

switch twice-daily insulin

"compare two different insuiln regimen in basal insuln base and premixed insulin.~NovoMix 30, drug class:biphasic insulins Lantus, drug class: long-acting insuiln Levemir, durg class: long-acting insulin NovoRapid, drug class: rapid-acting insulin"

Trial Locations (1)

Unknown

Mackay Memerial Hospital, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT02219750 - Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter